132 results
DEFA14A
VIR
Vir Biotechnology Inc
19 Apr 24
Additional proxy soliciting materials
8:35am
Materials
Soliciting Material Pursuant to §240.14a-12
Vir Biotechnology, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
8-K
EX-99.1
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. He joined … materials with the U.S. Securities and Exchange Commission (the “SEC”) in connection with the solicitation of proxies for the Annual Meeting
8-K
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
to the transfer of technology, materials, documentation and existing manufacturing commitments.
Except for the provisions of the Letter Agreement, the DCA
S-3ASR
EX-1.2
zgdx9afhw4t jhprx
3 Nov 23
Automatic shelf registration
4:33pm
DEFA14A
hvd84w81ml65pfmy0uzx
7 Apr 23
Additional proxy soliciting materials
4:09pm